Physician profile
Dil Patel
NPI 1871988303
$2,429.61
in general payments reported to CMS, 2019-2025
10 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $176 · 2021: $188 · 2022: $1,060 · 2023: $491 · 2024: $345 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,356.75 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $305.40 | 2021-2025 | Kyphon Express II Kyphopak Tray, Emprint, Osteocool Rf Ablation System |
| Medtronic USA, INC. | $176.10 | 2020 | |
| Avanos Medical | $142.24 | 2022 | |
| Kerecis Limited | $135.74 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Alexion Pharmaceuticals, INC. | $124.98 | 2023 | |
| Hologic Sales and Service, LLC | $103.42 | 2024 | 3dquorum, 3dimensions, Brevera Breast Biopsy System |
| Neurelis, INC. | $35.60 | 2022-2023 | Valtoco |
| Argenx US, INC. | $30.03 | 2023 | Vyvgart |
| Amgen INC. | $19.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.